[1]王 禅,陶 莹,焦庆仕.新冠肺炎疫情下我国新发传染病的应对及启示[J].卫生经济研究,2021,38(9):38-40.
　WANG Chan,TAO Ying,JIAO Qing-shi.The Countermeasures and Enlightenment of Emerging Infectious Diseases under COVID-19 Epidemic in China[J].Journal Press of Health Economics Research,2021,38(9):38-40.
点击复制

新冠肺炎疫情下我国新发传染病的应对及启示
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
38
期数:
2021年9期
页码:
38-40
栏目:
公共卫生
出版日期:
2021-08-26

文章信息/Info

Title:
The Countermeasures and Enlightenment of Emerging Infectious Diseases under COVID-19 Epidemic in China
作者:
王 禅1; 2; 陶 莹3; 焦庆仕4
1.中国医学科学院医学信息研究所, 北京 100023
2.北京师范大学社会发展与公共政策学院, 北京 100875
3.国家卫生健康委员会, 北京 100044
4.皖南医学院第一附属医院, 安徽 芜湖 241000
Author(s):
WANG Chan;  TAO Ying;  JIAO Qing-shi
Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing 100023, China
关键词:
新冠肺炎疫情; 传染病; 公共卫生; 疾控机构
Keywords:
COVID-19 epidemic;  infectious disease;  public health;  CDC
分类号:
R19
文献标志码:
A
摘要:
以新冠肺炎为代表的新发传染病多数具有病毒性病原、人畜共患的特征，对社会经济会造成重大损失，疾病负担较重。对此，应汲取新冠肺炎疫情的教训，扭转当前传染病防控相较于慢性病处于弱势地位的现状，将传染病防控纳入国家安全整体框架，理顺传染病监测预警体系，完善传染病法律法规体系；同时，强化疾病预防控制体系，创新传染病科研体系，重视公共卫生人才培养。
Abstract:
Most of the emerging infectious diseases represented by COVID-19 have the characteristics of viral pathogens and zoonotic diseases, which will cause major losses to the society and economy, and have heavy disease burden. In this regard, it should learn from the lessons of the COVID-19, reverse the current situation where the prevention and control of infectious diseases is at a weak position compared with chronic diseases, incorporate the prevention and control of infectious diseases into the overall national security framework, rationalize the infectious disease monitoring and warning system, and improve the infectious disease law system; at the same time, strengthen the disease prevention and control system, innovate the infectious disease scientific research system, and pay attention to the training of public health staffs.

参考文献/References:

[1] International Committee on Taxonomy of Viruses (ICTV).Virus Taxonomy:The ICTV Report on Virus Classification and Taxon Nomenclature [R]. 2011.
[2] 万平，陈洪.20 世纪以来流感在人群中的流行特征[J]. 生命的化学，2011,31（4）：605-611.
[3] 曾祥兴，李康生.流感百年：20 世纪流感大流行的回顾与启示[J].医学与社会，2010,23（11）：4-6.
[4] Taylor LH,Latham SM,Woolhouse MEPhilos Trans R Soc Lond B0 Risk factors for human disease emergence[J].Biol Sci,2001,356(1411):983.
[5] Centers for Disease and Control and Prevention.Bioterrorism Agents/Disease[EB/OL].[April 4,2018].https://emergency.cdc.gov/agent/agentlist-category.asp.
[6] 于保荣，许晴，刘卓,等.新发传染病经济负担的方法学研究[J]. 卫生经济研究,2017（7）：25-29.
[7] International Labour Organization.ILO Monitor:COVID-19 and the world of work. Fifth edition[R].30 June 2020.
[8] World Bank.The Global Economic Outlook During the COVID-19 Pandemic:A Changed World[EB/OL].[June 8,2020].https://www.worldbank.org/en/news/feature/2020/06/08/the-global-economic-outlook-during-the-covid-19-pandemic-a-changed-world.
[9] Tiffany L,Bogich Rumi Chunara, David Scales，et al. Preventing Pandemics via International Development:A Systems Approach[J].PLoS Med，2012，9(12):e1001354.
[10] 翟铁民，柴培培，魏强,等.我国慢性非传染性疾病卫生费用与筹资分析[J].中国卫生经济，2014,33（2）:14-17.
[11] 林健燕，郭泽强，施向东,等.甲型 H1N1 流感暴发疫情处置的卫生经济学评价[J].现代预防医学，2013,40（16）：3047-3053.
[12] 曾清宪，邓胜平，冯梅，等.湖南省儿童“五病”控制的成本效益分析[J] .实用预防医学，2006，13（2）269-273.
[13] 李华生,张辉,刘宏,等.昆明市甲肝、乙肝和伤寒疫苗接种效益分析[J] .中国健康教育,2008，24（7）：489-500.
[14] 刘民，刘改芬，王岩，等.北京市老年人群流行性感冒疫苗免疫效果及成本效益评价[J].中华流行病学杂志，2005，26（6）：412- 416.
[15] 赵丽梅.美国国家安全视野中的突发公共卫生事件对策研究（1992-2008）[D].沈阳：东北师范大学，2015.
[16] 陈方，张志强，丁陈君,等.美英日等国家生物安全战略要点及对中国建议[EB/OL].[2020-02-21].http://cn.chinagate.cn/news/2020-02/21/content_75730326.htm.
[17] World Bank,People,Pathogens and our Planet:The Economics of One Health,Washington,DC https://openknowledge.worldbank.org/handle/10986/11892,(2012) (License: CC BY 3.0 IGO).
[18] 刘国恩.进一步实现健康安全体系的长线建设[N].2020-05-07.
[19] 国家卫生健康委员会.2019中国卫生健康统计年鉴[M].北京：中国协和医科大学出版社，2019.

相似文献/References:

[1]董登姣,雷勇恒,梅路瑶.新冠肺炎疫情下公立医院财务管理探析[J].卫生经济研究,2020,(07):59.
　DONG Deng-jiao,LEI Yong-heng,MEI Lu-yao.Analysis of Financial Management in Public Hospitals under the Epidemic Situation of COVID-19[J].Journal Press of Health Economics Research,2020,(9):59.
[2]王 斌.新冠肺炎疫情影响下的浙江省公立医院经济运行分析[J].卫生经济研究,2020,(09):23.
　WANG Bin.Analysis on the Economic Operation of Public Hospitals in Zhejiang Province Under the Influence of COVID-19 Epidemic[J].Journal Press of Health Economics Research,2020,(9):23.
[3]蒋 昆,冯 娟,苏玉成.从“战疫”视角看医院信息化防控措施[J].卫生经济研究,2020,(10):60.
　JIANG Kun,FENG Juan,SU Yu-cheng.Prevention and Control Measures of Hospital Informatization from the Perspective of "Fighting Epidemic"[J].Journal Press of Health Economics Research,2020,(9):60.
[4]林哲明,石巧玲.职工医保的重大传染病巨灾风险管理研究——以新冠肺炎疫情为例[J].卫生经济研究,2021,38(6):32.
　LIN Zhe-ming,SHI Qiao-ling.Study on Catastrophe Risk Management of Major Infectious Diseases in Employee Medical Insurance——Take COVID-19 as an Example[J].Journal Press of Health Economics Research,2021,38(9):32.
[5]施 慧,汪青良,龚 杰.新形势下公立医院成本管理现状分析[J].卫生经济研究,2021,38(7):77.
　SHI Hui,WANG Qing-liang,GONG Jie.Analysis on the Status of Cost Management in Public Hospitals Under the New Situation[J].Journal Press of Health Economics Research,2021,38(9):77.
[6]王红伟.我国突发公共卫生事件应急管理体系建设研究[J].卫生经济研究,2021,38(9):41.
　WANG Hong-wei.Research on the Construction of Emergency Management System for Public Health Emergencies in China[J].Journal Press of Health Economics Research,2021,38(9):41.
[7]徐 州,高丽娜,唐 煌,等.新冠肺炎疫情对市级和区级中医院运营影响分析[J].卫生经济研究,2023,40(2):66.
　XU Zhou,GAO Lina,TANG Huang,et al.Analysis of the Impact of COVID-19 Epidemic on the Operation of Nanjing Municipal and District TCM Hospitals[J].Journal Press of Health Economics Research,2023,40(9):66.

更新日期/Last Update: 2021-08-26